The value of new drugs for advanced prostate cancer.
David H HowardRuben G W QuekKathleen M FoxBhakti ArondekarChristopher Paul FilsonPublished in: Cancer (2021)
The release of 5 new drugs coincided with increases in survival rates and spending. This study's estimates indicate that the new drugs collectively were cost-effective.